Brain Trust Accelerator Fund
Impact investorBurlingame · Seed–Series A · 1 people tracked
Find your way into Brain Trust Accelerator Fund
12 people in our graph share verified history with the Brain Trust Accelerator Fund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
The Brain Trust Accelerator Funds concentrate on translational-stage investments targeting the diagnosis and treatment of brain-related diseases, framed as impact investing in brain disease. According to the page, its Fund I generated top-tier returns, supported approaches intended to benefit up to ten million patients with brain diseases, and delivered $500,000 to charities. The firm expresses similar optimism about the prospects for its Fund II.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×2AI & Machine Learning ×1Digital Health ×1Medical Devices ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2016 · 12010 · 12 dated
NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCleveland, US
Co-investorsDolby Family Ventures
HealthtechBethesda, US
Michael E. Singer(Executive Officer, Director)inKerstin Schultz(Executive Officer)Laurie Silver(Executive Officer)
BoardJean Case(Director)Miles Gilburne(Director)
Board seatJohn M. Reher· per SEC Form D · $16.5M raise · filed Sep 2015
Co-investorsDBL PartnersRevolution
BiotechWashington, US
Thomas N. Chase(Executive Officer, Director)Douglas Ingram(Executive Officer, Director)John M. Siebert(Executive Officer, Director)Kathleen Clarence-Smith(Executive Officer)
BoardNayan Greg Parekh(Director)
Board seatJohn M. Reher· per SEC Form D · $612.5K raise · filed Feb 2016
Co-investorsAndera Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesBrainScope · forcefamilyoffice.com · Jul 24, 2025
Frequently asked questions
- What stage does Brain Trust Accelerator Fund invest at?
- Brain Trust Accelerator Fund invests at the Seed, Series A stages.
- What sectors does Brain Trust Accelerator Fund focus on?
- Brain Trust Accelerator Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Brain Trust Accelerator Fund located?
- Brain Trust Accelerator Fund is headquartered in Burlingame, US.
Similar investors
Pathway to Cures (P2C) is the venture philanthropy fund of the National Bleeding Disorders Foundation, focused on funding the development of transformational therapies and technologies for inheritable blood and bleeding disorders.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies focused exclusively on mental and neuro health.